These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16953197)
41. Setting the standard. Sandhu A Nat Nanotechnol; 2008 Feb; 3(2):63-4. PubMed ID: 18654456 [No Abstract] [Full Text] [Related]
42. A little regulation. Nature; 2006 Nov; 444(7119):520. PubMed ID: 17136053 [No Abstract] [Full Text] [Related]
43. U.S. regulatory aspects of standardization for nanotechnologies. Marrapese M; Wall G Stand News; 2005 Jul; 33(7):40-3. PubMed ID: 16237874 [No Abstract] [Full Text] [Related]
44. Toxicological and public good considerations for the regulation of nanomaterial-containing medical products. Faunce TA Expert Opin Drug Saf; 2008 Mar; 7(2):103-6. PubMed ID: 18324873 [TBL] [Abstract][Full Text] [Related]
45. Nanosilver: a test for nanotech regulation. Wilhelmi B Food Drug Law J; 2008; 63(1):89-112. PubMed ID: 18561456 [No Abstract] [Full Text] [Related]
46. Nanotechnology: using co-regulation to bring regulation of modern technologies into the 21st century. Reese M Health Matrix Clevel; 2013; 23(2):537-72. PubMed ID: 24341081 [No Abstract] [Full Text] [Related]
47. Nanotechnology in healthcare: are existing laws adequate? Munir AB; Yasin SH Eur J Health Law; 2007 Nov; 14(3):261-72. PubMed ID: 18229763 [No Abstract] [Full Text] [Related]
48. Re-processing of biological products: regulatory considerations from the CBER perspective. Shacter E Dev Biol (Basel); 2003; 113():105-7; discussion 115-6. PubMed ID: 14620859 [No Abstract] [Full Text] [Related]
49. Nanotechnology and the U.S. Food and Drug Administration. Marlowe DE Stand News; 2005 Jul; 33(7):29-31. PubMed ID: 16237872 [No Abstract] [Full Text] [Related]
50. Microwave effects on biological systems and nanoscience. Foreword. Kumar V Indian J Exp Biol; 2010 Oct; 48(10):954. PubMed ID: 21299037 [No Abstract] [Full Text] [Related]
52. Too small for concern? Public health and nanotechnology. Bowman DM; Fitzharris M Aust N Z J Public Health; 2007 Aug; 31(4):382-4. PubMed ID: 17725022 [TBL] [Abstract][Full Text] [Related]
53. What does the history of technology regulation teach us about nano oversight? Marchant GE; Sylvester DJ; Abbott KW J Law Med Ethics; 2009; 37(4):724-31. PubMed ID: 20122112 [TBL] [Abstract][Full Text] [Related]
54. Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations. Fan AM; Alexeeff G J Nanosci Nanotechnol; 2010 Dec; 10(12):8646-57. PubMed ID: 21121378 [TBL] [Abstract][Full Text] [Related]
55. Nanobiotech versus synthetic nanotech? Tabuchi M Nat Biotechnol; 2007 Apr; 25(4):389-90. PubMed ID: 17420738 [No Abstract] [Full Text] [Related]
56. Science, ethics, and the "problems" of governing nanotechnologies. Hogle LF J Law Med Ethics; 2009; 37(4):749-58. PubMed ID: 20122114 [TBL] [Abstract][Full Text] [Related]
57. Nanotechnology and the human future: policy, ethics, and risk. Cameron NM Ann N Y Acad Sci; 2006 Dec; 1093():280-300. PubMed ID: 17312264 [TBL] [Abstract][Full Text] [Related]
58. In the footsteps of biotech. Toumey C Nat Nanotechnol; 2010 Jul; 5(7):475. PubMed ID: 20606635 [TBL] [Abstract][Full Text] [Related]